The role of immunohistochemistry in predicting behavior of astrocytic tumors

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 4, 2010, Pages 1079-1084

  Moses Ambroise, M ^a   Khosla, Charu ^a   Ghosh, Mitra ^a   Mallikarjuna, V S ^a   Annapurneswari, S ^a  

^a Apollo Specialty Hospital   (India)

Author keywords

Astrocytomas; bcl 2; EGFR; p53

Indexed keywords

EID: 78650708930     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Ardeleanu C, Ceausu M, Butur G, et al (2005). p53 protein and bcl-2 expression in glioblastomas. Pathological correlations in a comprehensive series. Rom J Morphol Embryol, 46, 275-8.
2. Barker FG, Simmons ML, Chang SM, et al (2001). EGFR overexpression and radiation response in glioblastoma multiforme. Int J Radiat Oncol Biol Phys, 51, 410-8.
3. Chen P, Aldape K, Wiencke JK, et al (2001). Ethinicity delineates different genetic pathways in malignant glioma. Cancer Res, 61, 3949-54.
4. Cabrera-Munoz E, González-Arenas A, Saqui-Salces M, et al (2009). Regulation of progesterone receptor isoforms content in human astrocytoma cell lines. J Steroid Biochem Mol Biol, 113, 80-4.
5. Coulibaly B, Nanni I, Quilichini B, et al (2010). Epidermal growth factor receptor in glioblastomas: correlation between gene copy number and protein expression. Hum Pathol, 41, 815-23.
6. Das A, Tan W, Teo J, et al (2002). Glioblastoma multiforme in an Asian population:evidence for a distinct genetic pathway. J Neurooncol, 60, 117-25.
7. DiSapio A, Morra I, Pradotto L, et al (2002). Molecular genetic changes in a series of neuroepithelial tumors of childhood. J Neurooncol, 59, 117-22.
8. González-Agüero G, Gutiérrez AA, González-Espinosa D, et al (2007). Progesterone effects on cell growth of U373 and D54 human astrocytoma cell lines. Endocrine, 32, 129-35.
9. Houillier C, Lejeune J, Benouaich-Amiel A, et al (2006). Prognostic impact of molecular markers in a series of 220 primary glioblastomas. Cancer, 106, 2218-23.
10. Hollstein M, Hainaut P (2010). Massively regulated genes: The example of TP53. J Pathol, 220, 164-73.
11. Horbinski C, Hamilton RL, Lovell C, et al (2010). Impact of morphology, MIB-1, p53 and MGMT on outcome in pilocytic astrocytomas. Brain Pathol, 20, 581-8.
12. Ichimura K, Bolin MB, Goike HM, et al (2000). Deregulation of the p14ARF /MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities. Cancer Res, 60, 417-24.
13. Inoue T, Akahira J, Suzuki T, et al (2002). Progesterone production and actions in the human central nervous system and neurogenic tumors. J Clin Endocrinol Metab, 87, 5325-31.
14. Jiang H (2009). Overview of gefitinib in non-small cell lung cancer: an Asian perspective. Jpn J Clin Oncol, 39, 137-50.
15. Maiti AK, Ghosh K, Chatterjee U, et al (2008). Epidermal growth factor receptor and proliferating cell nuclear antigen in astrocytomas. Neurol India, 56, 456-62.
16. Martin V, Mazzucchelli L, Frattini M (2009). An overview of the epidermal growth factor receptor fluorescence in situ hybridization challenge in tumour pathology. J Clin Pathol, 62, 314-24.
17. Nakamizo A, Inamura T, Ikezaki K, et al (2002). Enhanced apoptosis in pilocytic astrocytoma: a comparative study of apoptosis and proliferation in astrocytic tumors. J Neurooncol, 57, 105-14.
18. Nayak A, Ralte AM, Sharma MC, et al (2004). P53 protein alterations in adult astrocytic tumors and oligodendrogliomas. Neurol India, 52, 228-32.
19. Ohgaki H, Dessen P, Jourde B, et al (2004). Genetic pathways to glioblastoma: A population-based study. Cancer Res, 64, 6892-9.
20. Okada Y, Hurwitz EE, Esposito JM, et al (2003). Selection pressures of TP53 mutation and microenvironmental location influence epidermal growth factor receptor gene amplification in human glioblastomas. Cancer Res, 63, 413-6.
21. Pardo FS, Hsu DW, Zeheb R, et al (2004). Mutant, wild type, or overall p53 expression: freedom from clinical progression in tumours of astrocytic lineage. Br J Cancer, 91, 1678-86.
22. Pallud J, Mandonnet E, Deroulers C, et al (2010). Pregnancy increases the growth rates of world health organization grade II gliomas. Ann Neurol, 67, 398-404.
23. Quan AL, Barnett GH, Lee S, et al (2005). Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys, 63, 695-703.
24. Rodriguez-Pereira C, Suarez-Penaranda JM, Barros F, et al (2001). Analysis of 2 antiapoptotic factors in gliomas: bcl-2 overexpression and p53 mutations. Arch Pathol Lab Med, 125, 218-23.
25. Ruano Y, Ribalta T, deLope AR, et al (2009). Worse outcome in primary glioblastoma multiforme with concurrent epidermal growth factor receptor and p53 alteration. Am J Clin Pathol, 131, 257-63.
26. Shinojima N, Tada K, Shiraishi S, et al (2003). Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme. Cancer Res, 63, 6962-70.
27. Stark AM, Hugo HH, Witzel P, et al (2003). Age-related expression of p53, Mdm2, EGFR and Msh2 in glioblastoma multiforme. Zentralbl Neurochir, 64, 30-6.
28. Steinbach JP, Weller M (2004). Apoptosis in gliomas: Molecular mechanisms and therapeutic implications. J Neurooncol, 70, 245-54.
29. Tihan T, Davis R, Elowitz E, et al (2000). Practical value of Ki-67 and p53 labeling indexes in stereotactic biopsies of diffuse and pilocytic astrocytomas. Arch Pathol Lab Med, 124, 108-13.
30. Tyagi D, Sharma BS, Gupta SK, et al (2002). Expression of Bcl2 proto-oncogene in primary tumors of the central nervous system. Neurol India, 50, 290-4.
31. Tibbetts KM, Emnett RJ, Gao F, et al (2009). Histopathologic predictors of pilocytic astrocytoma event-free survival. Acta Neuropathol, 117, 657-65.
32. Wiencke JK, Aldape K, McMillan A, et al (2005). Molecular features of adult glioma associated with patient race/ethnicity, age, and a polymorphism in O6-methylguanine-DNA-methyltransferase. Cancer Epidemiol Biomarkers Prev, 14, 1774-83.
33. Xie D, Zeng YX, Wang HJ, et al (2005). Amplification and overexpression of epidermal growth factor receptor gene in glioblastomas of Chinese patients correlates with patient's age but not with tumor's clinicopathological pathway. Acta Neuropathol, 110, 481-9.
34. Yeole BB (2008). Trends in the brain cancer incidence in India. Asian Pacific J Cancer Prev, 9, 267-70.
35. Yue WY, Yu SH, Zhao SG, et al (2009). Molecular markers relating to malignant progression in grade II astrocytomas. J Neurosurg, 110, 709-14.